Alex A. Adjei

Also affiliated with Case Comprehensive Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Guidelines for Statistical Reporting in Medical Journals”.

Guidelines for Statistical Reporting in Medical Journals

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.019

N/A

0DataRank · unranked

28 citations

Jennifer Le‐Rademacher, Karla V. Ballman, Alex A. Adjei, Sumithra J. Mandrekar, Fang‐Shu Ou

Survival of Black and White Patients With Stage IV Small Cell Lung Cancer

Frontiers in Oncology(2021)10.3389/fonc.2021.773958

N/A

0DataRank · unranked

2 citations

Kexun Zhou, Jordan J. Cochuyt, David O. Hodge, Hong Qin, Rami Manochakian +5 more

Oncologists’ views on Expanded Access and Right-to-Try: The need for education and shared decision-making.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e13603

N/A

0DataRank · unranked

0 citations

Cambray Smith, Jeremiah Stout, Alex A. Adjei, Jan C. Buckner, Jon C. Tilburt +1 more

A Clinician’s Guide to Bioinformatics for Next-Generation Sequencing

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.11.006

N/A

0DataRank · unranked

68 citations

Ann L. Oberg, Alex A. Adjei, Liguo Wang, Nicholas B. Larson

Results of the DIAL study (NCI 10089), a randomized phase 2 trial of varlilumab combined with nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma (r/r B-NHL).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.17_suppl.lba7564

N/A

0DataRank · unranked

3 citations

Justin Kline, Aleksandr Lazaryan, Nancy L. Bartlett, Francisco J. Hernandez‐Ilizaliturri, Farrukh T. Awan +13 more

Population Pharmacokinetics of Z‐Endoxifen in Patients With Advanced Solid Tumors

The Journal of Clinical Pharmacology(2022)10.1002/jcph.2053

N/A

0DataRank · unranked

0 citations

Andrew T. Ralya, Thomas R. Larson, Renee M. McGovern, Sarah A. Buhrow, Joseph M. Covey +6 more

Phase 1/2 trial of vesicular stomatitis virus expressing human interferon-β and NIS (VSV-IFNβ-NIS), with pembrolizumab, in patients with neuroendocrine carcinoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps657

N/A

0DataRank · unranked

6 citations

Shruthi Naik, Þorvarður R. Hálfdánarson, Konstantinos Leventakos, Kah Whye Peng, Stephen J. Russell +3 more

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma

Lung Cancer(2024)10.1016/j.lungcan.2024.107928

N/A

0DataRank · unranked

16 citations

Jun Vivien Yin, Penelope A. Bradbury, David J. Kwiatkowski, Shiven B. Patel, Lyudmila Bazhenova +24 more

Neutrophil to lymphocyte ratio varies in magnitude and biomarker utility based on patient demographics

Journal of Clinical Investigation(2025)10.1172/jci198948

N/A

0DataRank · unranked

2 citations

Travis Kerr, Ananya Kodiboyena, Cristina Valero, Joris L. Vos, Vladimir Makarov +7 more